UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
Position in BLLN — BillionToOne, Inc.
CIK 861177
NEW YORK, NY
Position in BLLN
as of Mar 31, 2026
· filed May 13, 2026
Position Value
$18,991,936
+$360,652 QoQ
Shares Held
240,587
+5.7% QoQ
Ownership
0.523%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 31%
Shared 0%
None 69%
Common Shares in BLLN Over Time
Shares Held
Position Value (USD)
Position in Diagnostics & Research
Healthcare · as of Mar 31, 2026UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds $4,972,110,878 across 32 Diagnostics & Research names. BLLN ranks #18 (0.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TMO |
Thermo Fisher Scientific Inc.
|
2,449,697 | $1,204,099,562 | |
| 2 | DHR |
Danaher Corp /De/
|
5,225,861 | $990,823,242 | |
| 3 | IDXX |
Idexx Laboratories Inc /De
|
871,789 | $489,849,516 | |
| 4 | MTD |
Mettler Toledo International Inc/
|
241,360 | $304,403,227 | |
| 5 | A |
Agilent Technologies, Inc.
|
2,646,458 | $301,643,277 | |
| 6 | IQV |
Iqvia Holdings Inc.
|
1,499,267 | $255,684,990 | |
| 7 | LH |
Labcorp Holdings Inc.
|
900,202 | $240,182,890 | |
| 8 | WAT |
Waters Corp /De/
|
794,589 | $236,628,599 |
All Filings in BLLN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $18,991,936 | 240,587 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $18,631,284 | 227,655 | Shares | Sole | 2026-02-13 | |
| No filing history on record for this holder in this stock. | ||||||